Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The Canadian Drug Agency assessed Wegovy's cost-effectiveness in July 2025 and recommended a price reduction, and December 2025 negotiations between the pan-Canadian Pharmaceutical Alliance and Novo Nordisk concluded without agreement
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access We are sorry, but there is no personal subscription option available for your country
The injectable medicine, sold and patented by Eli Lilly and Company, contains the active ingredient tirzepatide, which was first approved under the brand name Mounjaro in May 2022 to improve glycemic control in people with Type 2 diabetes
At the 2025 American Psychiatric Association meeting, researchers reported that smokers on GLP-1s gained virtually no weight at eight weeks and were 18 percent less likely to relapse than controls in counseling-only programs
Thats one of the stories that really stuck to me because the kid had nothing to do with it
Baseline Assumptions Average U.S
US$ 24.88
US$ 20.62
US$ 23.16
US$ 22.69
